Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review

Clostridium difficile infections are a global clinical concern and are one of the leading causes of nosocomial outbreaks. Preventing these infections has benefited from multidisciplinary infection control strategies and new antibiotics, but the problem persists. Probiotics are effective in preventin...

Full description

Bibliographic Details
Main Author: Lynne V. McFarland
Format: Article
Language:English
Published: MDPI AG 2015-04-01
Series:Antibiotics
Subjects:
Online Access:http://www.mdpi.com/2079-6382/4/2/160
id doaj-a1b56589d18b41c5a13ab677d8c0bc78
record_format Article
spelling doaj-a1b56589d18b41c5a13ab677d8c0bc782020-11-25T01:04:41ZengMDPI AGAntibiotics2079-63822015-04-014216017810.3390/antibiotics4020160antibiotics4020160Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewLynne V. McFarland0Department of Medicinal Chemistry, University of Washington, VA Puget Sound Healthcare System, 1660 S. Columbian Way, S-152, Seattle, WA 98108, USAClostridium difficile infections are a global clinical concern and are one of the leading causes of nosocomial outbreaks. Preventing these infections has benefited from multidisciplinary infection control strategies and new antibiotics, but the problem persists. Probiotics are effective in preventing antibiotic-associated diarrhea and may also be a beneficial strategy for C. difficile infections, but randomized controlled trials are scarce. This meta-analysis pools 21 randomized, controlled trials for primary prevention of C. difficile infections (CDI) and four trials for secondary prevention of C. difficile recurrences and assesses the efficacy of specific probiotic strains. Four probiotics significantly improved primary CDI prevention: (Saccharomyces boulardii, Lactobacillus casei DN114001, a mixture of L. acidophilus and Bifidobacterium bifidum, and a mixture of L. acidophilus, L. casei and L. rhamnosus). None of the tested probiotics significantly improved secondary prevention of CDI. More confirmatory randomized trials are needed to establish if probiotics are useful for preventing C. difficile infections. vhttp://www.mdpi.com/2079-6382/4/2/160probioticsclostridium difficile infectionsdiarrheameta-analysisv
collection DOAJ
language English
format Article
sources DOAJ
author Lynne V. McFarland
spellingShingle Lynne V. McFarland
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
Antibiotics
probiotics
clostridium difficile infections
diarrhea
meta-analysisv
author_facet Lynne V. McFarland
author_sort Lynne V. McFarland
title Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
title_short Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
title_full Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
title_fullStr Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
title_full_unstemmed Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
title_sort probiotics for the primary and secondary prevention of c. difficile infections: a meta-analysis and systematic review
publisher MDPI AG
series Antibiotics
issn 2079-6382
publishDate 2015-04-01
description Clostridium difficile infections are a global clinical concern and are one of the leading causes of nosocomial outbreaks. Preventing these infections has benefited from multidisciplinary infection control strategies and new antibiotics, but the problem persists. Probiotics are effective in preventing antibiotic-associated diarrhea and may also be a beneficial strategy for C. difficile infections, but randomized controlled trials are scarce. This meta-analysis pools 21 randomized, controlled trials for primary prevention of C. difficile infections (CDI) and four trials for secondary prevention of C. difficile recurrences and assesses the efficacy of specific probiotic strains. Four probiotics significantly improved primary CDI prevention: (Saccharomyces boulardii, Lactobacillus casei DN114001, a mixture of L. acidophilus and Bifidobacterium bifidum, and a mixture of L. acidophilus, L. casei and L. rhamnosus). None of the tested probiotics significantly improved secondary prevention of CDI. More confirmatory randomized trials are needed to establish if probiotics are useful for preventing C. difficile infections. v
topic probiotics
clostridium difficile infections
diarrhea
meta-analysisv
url http://www.mdpi.com/2079-6382/4/2/160
work_keys_str_mv AT lynnevmcfarland probioticsfortheprimaryandsecondarypreventionofcdifficileinfectionsametaanalysisandsystematicreview
_version_ 1725196746998415360